FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Parasitol / Chemotherapy of surra in horses and mules with diminazene ac...
Veterinary parasitology2002; 110(3-4); 227-233; doi: 10.1016/s0304-4017(02)00304-7

Chemotherapy of surra in horses and mules with diminazene aceturate.

Abstract: During June-July 2000, an outbreak of surra occurred on an equine breeding farm in Khonkaen Province, Thailand. Forty-two percent of pregnant mares aborted or gave stillbirth and 40% (19/47) of horses and 10% (1/10) of mules died from surra. In August 2000 Trypanosoma evansi were detected in the remaining animals (28 horses and nine mules) on the farm by blood smear and/or the haematocrit centrifuge technique. All animals were treated with diminazene aceturate at 3.5 mg/kg body weight by intramuscular injection on days 0 and 41 of the study. Blood samples of eight randomly selected horses and mules were collected on days 0, 1 and once a week until day 56 and examined for T. evansi by various parasitological techniques. The sera were tested for antibodies against T. evansi using an indirect enzyme linked immunosorbent assay (ELISA).The results revealed that diminazene aceturate at 3.5 mg/kg appeared to be effective in the first treatment of horses and mules infected with T. evansi. Parasites were cleared from the peripheral blood of horses on days 1 and 7 and mules on days 1 and 14. Thereafter the number of positive animals increased. After the second treatment, 50% of horses and 25% of mules were still positive to surra 24 h after treatment demonstrating that diminazene had no protective effect. Mild to severe toxicity of diminazene was seen in the horses and mules after injection.
Get Full Text
Publication Date: 2002-12-17 PubMed ID: 12482651DOI: 10.1016/s0304-4017(02)00304-7Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Clinical Trial
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the effect of the drug diminazene aceturate on treating surra, a deadly disease in horses and mules caused by the parasite Trypanosoma evansi, during an outbreak in Thailand. The results suggest initial effectiveness in clearing parasites but show that the drug does not prevent reinfection and can cause toxic side effects.

Research Context and Aim

  • This study was conducted in response to a significant outbreak of surra, a fatal parasitic disease, at an equine breeding farm in Khonkaen Province, Thailand in 2000. The disease led to severe losses, including abortions or stillbirths in 42% of pregnant mares and the death of 40% of the horses and 10% of mules.
  • The objective of the research was to evaluate the effectiveness of diminazene aceturate as a treatment for horses and mules infected with the causative parasite, Trypanosoma evansi.

Research Methodology

  • All remaining animals on the farm affected by the outbreak, comprising of 28 horses and nine mules, were treated with diminazene aceturate. The drug was given at a dose of 3.5 mg/kg body weight via intramuscular injections on days 0 and 41 of the study.
  • The researchers collected and analyzed blood samples from randomly selected animals on various days, including the day of the first treatment (day 0), the next day (day 1), and once a week until day 56 of the study.
  • The researchers utilized a range of parasitological techniques to examine T. evansi populations. They also employed an indirect enzyme-linked immunosorbent assay (ELISA) to test for antibodies against T. evansi in the animals’ sera.

Research Findings

  • The results suggested that the first dose of diminazene aceturate cleared parasites from the peripheral blood of the horses on days 1 and 7 and mules on days 1 and 14.
  • After this initial success, the number of animals testing positive for the parasite increased again. This indicated the drug’s limited effectiveness as it failed to protect against reinfection.
  • Following the second administration of the drug, 50% of the horses and 25% of mules were found to be still infected with surra. This substantiated the drug’s lack of protective effect.
  • A notable detrimental finding was the observation of mild to severe toxicity in horses and mules post drug injection, indicating potential adverse side effects of diminazene aceturate treatment.

Cite This Article

APA
Tuntasuvan D, Jarabrum W, Viseshakul N, Mohkaew K, Borisutsuwan S, Theeraphan A, Kongkanjana N. (2002). Chemotherapy of surra in horses and mules with diminazene aceturate. Vet Parasitol, 110(3-4), 227-233. https://doi.org/10.1016/s0304-4017(02)00304-7

Publication

Veterinary parasitology
ISSN: 0304-4017
NlmUniqueID: 7602745
Country: Netherlands
Language: English
Volume: 110
Issue: 3-4
Pages: 227-233

Researcher Affiliations

Tuntasuvan, D
  • National Institute of Animal Health, Kasetklang, Bangkhen, Jatujak, Bangkok 10900, Thailand. tdarunee@hotmail.com
Jarabrum, W
    Viseshakul, N
      Mohkaew, K
        Borisutsuwan, S
          Theeraphan, A
            Kongkanjana, N

              MeSH Terms

              • Animals
              • Antibodies, Protozoan / blood
              • Creatine / blood
              • Diminazene / adverse effects
              • Diminazene / analogs & derivatives
              • Diminazene / therapeutic use
              • Equidae / parasitology
              • Female
              • Horse Diseases / drug therapy
              • Horse Diseases / parasitology
              • Horses / parasitology
              • Male
              • Pregnancy
              • Thailand
              • Trypanocidal Agents / adverse effects
              • Trypanocidal Agents / therapeutic use
              • Trypanosoma / immunology
              • Trypanosoma / isolation & purification
              • Trypanosomiasis / drug therapy
              • Trypanosomiasis / veterinary

              Citations

              This article has been cited 23 times.
              1. Raftery AG, Gummery L, Garcia K, Mohite D, Capewell P, Sutton D. Equine trypanosomiasis, a systematic review: Disease management. Equine Vet J 2026 Mar;58(2):320-332.
                doi: 10.1002/evj.70136pubmed: 41429593google scholar: lookup
              2. Ullah A, Geng M, Chen W, Zhu Q, Shi L, Zhang X, Akhtar MF, Wang C, Khan MZ. Effect of Parasitic Infections on Hematological Profile, Reproductive and Productive Performance in Equines. Animals (Basel) 2025 Nov 14;15(22).
                doi: 10.3390/ani15223294pubmed: 41302002google scholar: lookup
              3. Raftery AG, Gummery L, Garcia K, Mohite D, Capewell P, Sutton DGM. Equine trypanosomiasis, a systematic review and meta-analyses: Prevalence, morbidity and mortality. Equine Vet J 2026 Mar;58(2):291-319.
                doi: 10.1111/evj.70101pubmed: 41131780google scholar: lookup
              4. Cardillo NM, Villarino NF, Lacy PA, Doggett JS, Riscoe MK, Suarez CE, Ueti MW, Chung CJ. Enhanced Anti-Babesia Efficacy of Buparvaquone and Imidocarb When Combined with ELQ-316 In Vitro Culture of Babesia bigemina. Pharmaceuticals (Basel) 2025 Feb 6;18(2).
                doi: 10.3390/ph18020218pubmed: 40006032google scholar: lookup
              5. Phetkarl T, Fungwithaya P, Lewchalermvong K, Sontigun N. Prevalence of gastrointestinal and blood parasites in horses of Nakhon Si Thammarat province, Thailand. Vet World 2024 Nov;17(11):2460-2468.
                doi: 10.14202/vetworld.2024.2460-2468pubmed: 39829659google scholar: lookup
              6. Cardillo NM, Villarino NF, Lacy PA, Riscoe MK, Doggett JS, Ueti MW, Chung CJ, Suarez CE. The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against Babesia bovis In Vitro. Pharmaceutics 2024 Oct 31;16(11).
                doi: 10.3390/pharmaceutics16111402pubmed: 39598526google scholar: lookup
              7. Suganuma K, Mochabo KM, Chemuliti JK, Kiyoshi K, Noboru I, Kawazu SI. Ascofuranone antibiotic is a promising trypanocidal drug for nagana. Onderstepoort J Vet Res 2024 Feb 8;91(1):e1-e6.
                doi: 10.4102/ojvr.v91i1.2115pubmed: 38426744google scholar: lookup
              8. Bhutia WD, Gupta S, Rani R, Batra K, Sethi K, Kumar S, Kumar R. In vitro and in vivo evaluation of kinase and protease inhibitors against Trypanosoma evansi. Vet Res Commun 2023 Jun;47(2):473-485.
                doi: 10.1007/s11259-022-09964-xpubmed: 35751782google scholar: lookup
              9. Aregawi WG, Gutema F, Tesfaye J, Sorsa A, Megersa B, Teshome P, Agga GE, Ashenafi H. Efficacy of diminazene diaceturate and isometamidium chloride hydrochloride for the treatment of Trypanosoma evansi in mice model. J Parasit Dis 2021 Mar;45(1):131-136.
                doi: 10.1007/s12639-020-01289-3pubmed: 33746398google scholar: lookup
              10. Mizushima D, Amgalanbaatar T, Davaasuren B, Kayano M, Naransatsral S, Myagmarsuren P, Otgonsuren D, Enkhtaivan B, Davkharbayar B, Mungun-Ochir B, Baatarjargal P, Nyamdolgor U, Soyolmaa G, Altanchimeg A, Zoljargal M, Nguyen TT, Battsetseg B, Battur B, Inoue N, Yokoyama N, Suganuma K. Nationwide serological surveillance of non-tsetse-transmitted horse trypanosomoses in Mongolia. Parasite Epidemiol Control 2020 Aug;10:e00158.
                doi: 10.1016/j.parepi.2020.e00158pubmed: 32642568google scholar: lookup
              11. Camoin M, Kocher A, Chalermwong P, Yangtarra S, Kamyingkird K, Jittapalapong S, Desquesnes M. The Indirect ELISA Trypanosoma evansi in Equids: Optimisation and Application to a Serological Survey including Racing Horses, in Thailand. Biomed Res Int 2019;2019:2964639.
                doi: 10.1155/2019/2964639pubmed: 31886196google scholar: lookup
              12. Nugraha AB, Tuvshintulga B, Guswanto A, Tayebwa DS, Rizk MA, Gantuya S, El-Saber Batiha G, Beshbishy AM, Sivakumar T, Yokoyama N, Igarashi I. Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites. Int J Parasitol Drugs Drug Resist 2019 Aug;10:84-90.
                doi: 10.1016/j.ijpddr.2019.06.004pubmed: 31254719google scholar: lookup
              13. Raftery AG, Jallow S, Rodgers J, Sutton DGM. Safety and efficacy of three trypanocides in confirmed field cases of trypanosomiasis in working equines in The Gambia: a prospective, randomised, non-inferiority trial. PLoS Negl Trop Dis 2019 Mar;13(3):e0007175.
                doi: 10.1371/journal.pntd.0007175pubmed: 30901321google scholar: lookup
              14. Aregawi WG, Agga GE, Abdi RD, Büscher P. Systematic review and meta-analysis on the global distribution, host range, and prevalence of Trypanosoma evansi. Parasit Vectors 2019 Jan 31;12(1):67.
                doi: 10.1186/s13071-019-3311-4pubmed: 30704516google scholar: lookup
              15. Duarte DP, Ferreira ÉR, Lima FM, Batista F, De Groote M, Horjales E, Miletti LC, Bahia D. Molecular Characterization of Trypanosoma evansi Mevalonate Kinase (TeMVK). Front Cell Infect Microbiol 2018;8:223.
                doi: 10.3389/fcimb.2018.00223pubmed: 30042928google scholar: lookup
              16. Giordani F, Morrison LJ, Rowan TG, DE Koning HP, Barrett MP. The animal trypanosomiases and their chemotherapy: a review. Parasitology 2016 Dec;143(14):1862-1889.
                doi: 10.1017/S0031182016001268pubmed: 27719692google scholar: lookup
              17. Desquesnes M, Dargantes A, Lai DH, Lun ZR, Holzmuller P, Jittapalapong S. Trypanosoma evansi and surra: a review and perspectives on transmission, epidemiology and control, impact, and zoonotic aspects. Biomed Res Int 2013;2013:321237.
                doi: 10.1155/2013/321237pubmed: 24151595google scholar: lookup
              18. Lewis KM, Cohn LA, Marr HS, Birkenheuer AJ. Failure of efficacy and adverse events associated with dose-intense diminazene diaceturate treatment of chronic Cytauxzoon felis infection in five cats. J Feline Med Surg 2014 Feb;16(2):157-63.
                doi: 10.1177/1098612X13502974pubmed: 24043719google scholar: lookup
              19. Kumar U, Jas R, Ghosh JD. Effect of isometamidium hydrochloride on Trypanosoma evansi infections in rats. J Parasit Dis 2009 Dec;33(1-2):36-41.
                doi: 10.1007/s12639-009-0006-3pubmed: 23129886google scholar: lookup
              20. Ranjithkumar M, Malik TA, Saxena A, Dan A, Sakthivel PC, Dey S. Hyperlipidaemia in trypanosomiasis of naturally infected horses: possible cachexia-anorexia syndrome?. Trop Anim Health Prod 2013 Feb;45(2):417-21.
                doi: 10.1007/s11250-012-0232-zpubmed: 22836485google scholar: lookup
              21. Da Silva AS, Fanfa VR, Otto MA, Gressler LT, Tavares KC, Lazzarotto CR, Tonin AA, Miletti LC, Duarte MM, Monteiro SG. Susceptibility of mice to Trypanosoma evansi treated with human plasma containing different concentrations of apolipoprotein L-1. Korean J Parasitol 2011 Dec;49(4):427-30.
                doi: 10.3347/kjp.2011.49.4.427pubmed: 22355213google scholar: lookup
              22. Roy N, Nageshan RK, Pallavi R, Chakravarthy H, Chandran S, Kumar R, Gupta AK, Singh RK, Yadav SC, Tatu U. Proteomics of Trypanosoma evansi infection in rodents. PLoS One 2010 Mar 22;5(3):e9796.
                doi: 10.1371/journal.pone.0009796pubmed: 20339546google scholar: lookup
              23. McGrath AP, Hilmer KM, Collyer CA, Shepard EM, Elmore BO, Brown DE, Dooley DM, Guss JM. Structure and inhibition of human diamine oxidase. Biochemistry 2009 Oct 20;48(41):9810-22.
                doi: 10.1021/bi9014192pubmed: 19764817google scholar: lookup
              Subscribe to our newsletter
              Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.